Heterozygous mutations in RYR2 cause cardiac arrhythmias including Catecholaminergic polymorphic ventricular tachycardia (CPVT) that are characterized by exercise-induced syncope, sudden cardiac arrest or sudden cardiac death. This evidence concerns the gene RYR2 and chronic obstructive pulmonary disease.